United Kingdom
UK / English
Choose your region
Choose your language
Register
Mast_Group.svg
ProductsMarketsAboutNews & EventsResourcesCareers
Contact us
ProductsMarketsAboutNews & EventsResourcesCareers
logo-mast.svg
+44 (0) 151 933 7277
Email us
Sign up to Newsletter
Products
  • Gastrointestinal Diseases
  • Immunology
  • Microbiology
  • Molecular
  • Pharmaceutical Services
  • Urinalysis
Markets
  • Clinical Diagnostics
  • FIT testing
  • Infectious Disease
  • Pharmaceutical & Industrial
  • Veterinary
About
  • Our Culture
  • Our Governance
  • Our History
  • Our Locations
  • Our Partners
  • Our Quality
Resources
  • FAQs
  • Certificates of Analysis
  • Quality Certification
News & Events
  • News
  • Events
  • Blog
United Kingdom
UK / English
Manage Cookies|
Terms & conditions|
Data Protection|
Ordering Information|
Conditions of Purchase|
Modern Slavery
|Update cookie preferences|© Mast Group Ltd. 2026 Mast Group Limited is a limited company registered in England and Wales with registered number 00632512. Our registered office is at Mast House, Derby Road, Liverpool, L20 1EA.
Follow Us
LinkedIn.svgUK
© Mast Group Ltd. 2026 Mast Group Limited is a limited company registered in England and Wales with registered number 00632512. Our registered office is at Mast House, Derby Road, Liverpool, L20 1EA.
Home
Identification & DetectionReceptor Destroying Enzyme

Receptor Destroying Enzyme

Explore our Receptor Destroying Enzyme Products

MAST® Assure AntiseraBiochemical Identification MediaMAST® IDReceptor Destroying EnzymeAntibiotic Resistance Detection Sets

Accurate haemagglutination inhibition testing for influenza relies on the effective removal of non-specific inhibitors from human serum before testing begins.

MAST® RDE II (Receptor Destroying Enzyme) provides a reliable solution for this critical preparatory step, eliminating serum inhibitors that would otherwise interfere with test results and compromise the integrity of influenza virus detection.

Simple to use, RDE II is available for research use.

RDE (II) Receptor Destroying Enzyme
Identification & Detection
RDE (II) Receptor Destroying Enzyme
370013
RDE II (Receptor Destroying Enzyme) is designed to remove non-specific inhibitors from human serum, enabling accurate hemagglutination inhibition (HI) testing for influenza viruses. Intended for research use only.
More Info

Explore our Microbiology Solutions

AST

UK_AST_Discs1.pngUK_AST_Discs1.pngUK_AST_Discs1.pngUK_AST_Discs1.png

Culture Media & Supplements

SELECTAB_MKT2.jpgSELECTAB_MKT2.jpgSELECTAB_MKT2.jpgSELECTAB_MKT2.jpg

AMR

AMR_CATEGORY_PLATES.jpgAMR_CATEGORY_PLATES.jpgAMR_CATEGORY_PLATES.jpgAMR_CATEGORY_PLATES.jpg

Instruments

Dispenser.jpgDispenser.jpgDispenser.jpgDispenser.jpg

Sample Storage

misc_cryobank_cryoblock.jpgmisc_cryobank_cryoblock.jpgmisc_cryobank_cryoblock.jpgmisc_cryobank_cryoblock.jpg

Identification & Detection

id_latex_rst501_contents.jpgid_latex_rst501_contents.jpgid_latex_rst501_contents.jpgid_latex_rst501_contents.jpg